To advance medical research in cell-specific targeting of therapeutic agents for catastrophic medical diseases.
To offer innovative biotechnology solutions through cell-specific targeting of therapeutic agents that will implement clinical solutions and therapies for pandemic infectious diseases, autoimmune disorders, and cancers.
We support novel and promising Proof of Concept research into cell-specific targeted treatments of catastrophic diseases which have significant global impact. We believe there is an unfilled niche for funding creative and potentially important medical developments by scientists who are unable to obtain early grants from existing funding sources.
We will issue an annual request for proposals in three disease areas, to be announced by our Science Advisory Committee. Initially, we will review research proposals for targeted therapeutics in oncology, infectious diseases, and neurodegenerative disorders. Proposals will be independently reviewed and evaluated by the Science Advisory Committee. Grants for a maximum of $50,000 will be awarded in each of the designated disease areas, based on merit.